Stephanie Reading is currently the Director of Observational Research at Amgen, where they serve as the Global Product Lead for Bemarituzumab in the Oncology Therapeutic Area. Previously, they held several positions at Amgen, including Senior Manager and Manager in the Center for Observational Research, specializing in the cardiovascular therapeutic area with a focus on Repatha. Stephanie also has experience as a Research Fellow at the Mayo Clinic and as a Post Doctoral Research Fellow at Kaiser Permanente. They earned a BS in Neuroscience from the University of Michigan and are pursuing both a PhD in Epidemiology at UCLA and an MPH in Behavioral Sciences and Health Education at Emory University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices